Clinical Trials Directory

Trials / Unknown

UnknownNCT05188365

Acupuncture Efficacy on Lipids in Tinnitus Patients With Obesity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
35 Years – 45 Years
Healthy volunteers
Not accepted

Summary

nowadays, published literature affirms strong relation between tinnitus, obesity, and high lipids of blood.

Detailed description

For 8 weeks, our study will search effect of acupuncture on tinnitus (chronic subjective type), lipids and weight reduction in obese persons.

Conditions

Interventions

TypeNameDescription
OTHERtrue acupuncturedifferent body acupuncture points will be selected to be manually punctured in addition to 4 acupoints on the skin of abdominal surface (the four points will be electrical stimulated during acupuncture). the session (20 minutes) will repeated thrice weekly. the total duration of the study will be 60 days. The points that will be manually acupunctured all over the body of every patient will be: SJ(3)/SJ(5)/SJ(17)/SJ(18)/SJ(19)/SJ(20)/SJ(21)/SJ(22)/GB(2)/GB(8)/GB(20)/LI(4)/LI(11)/KI(3)/SP(6)/ST(36)/REN(4)/REN(9)/REN(12) The acupuncture points that will be electrically stimulated on the abdomen of every patient will be: bilateral Stomach 25 in addition to gallbladder 28 acupoints.
OTHERsham acupuncturedifferent body acupuncture points will be selected to be manually punctured in addition to 4 acupoints on the skin of abdominal surface (the four points will be electrical stimulated during acupuncture). opposite to group A, in this group, the acupuncture needles will be inserted manually and very adjacent to the real location of group-A acupoints (sham acupuncture). The electrical stimulator will connected to abdominal acupoints (bilateral Stomach 25 in addition to gallbladder 28 acupoints) but it will be turned off during the sessions. the session will repeated thrice weekly. the total duration of the study will be 60 days

Timeline

Start date
2021-12-06
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2022-01-12
Last updated
2022-01-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05188365. Inclusion in this directory is not an endorsement.